Keyphrases
Cardiotoxicity
100%
Anthracyclines
100%
Gene Response
100%
Shared Genetics
100%
Top2
100%
Response Signature
100%
Doxorubicin
30%
Cardiomyocytes
20%
Responsive Genes
20%
Induced Pluripotent Stem Cells (iPSCs)
20%
Doxorubicin Treatments
20%
Trastuzumab
20%
Gene Expression Changes
20%
Epirubicin
20%
Daunorubicin
20%
Mitoxantrone
20%
Expression Quantitative Trait Loci (eQTL)
20%
Cancer Patients
10%
Adverse Effects
10%
Breast Cancer Treatment
10%
Monoclonal Antibody
10%
Cell Death
10%
Breast Cancer Patients
10%
Sustained Response
10%
In Cancer
10%
Treatment Effect
10%
Healthy Women
10%
Lethal Dose
10%
Between-person
10%
Individual-based
10%
Non-response
10%
Cellular Stress
10%
Specific Signature
10%
Effective Compounds
10%
SNP
10%
Risk Profile
10%
Inter-individual Variation
10%
Gene-gene
10%
Patient Serum
10%
Calcium Handling
10%
Late Response
10%
Early Response Genes
10%
Genetic Effects
10%
Response Variability
10%
Directional Effects
10%
Chromatin Regulators
10%
Anthraquinone
10%
Cardiomyocyte Contraction
10%
Transcriptional Variation
10%
Anthracycline Toxicity
10%
Anthracycline-induced Cardiotoxicity
10%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
Anthracycline
100%
Doxorubicin
71%
Cardiac Muscle Cell
42%
Induced Pluripotent Stem Cell
28%
Daunorubicin
28%
Trastuzumab
28%
Expression Quantitative Trait Loci
28%
Epirubicin
28%
Monoclonal Antibody
14%
Genetic Determinism
14%
Cell Death
14%
Single Nucleotide Polymorphism
14%
Cell Stress
14%
Early Response Gene
14%
Genome Wide Association Study
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiotoxicity
100%
Anthracycline
100%
Doxorubicin
83%
Breast Cancer
33%
Trastuzumab
33%
Epirubicin
33%
Daunorubicin
33%
Mitoxantrone
33%
Malignant Neoplasm
16%
Adverse Event
16%
Monoclonal Antibody
16%
Anthraquinone
16%
Anthracycline Toxicity
16%